{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:56:09Z","timestamp":1793836569706,"version":"4.6.1"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41375-025-02804-2","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:28:11Z","timestamp":1765186091000},"page":"3-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2748-4001","authenticated-orcid":false,"given":"Theis","family":"Mikkelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3613-8338","authenticated-orcid":false,"given":"Marianne","family":"Helenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Ampatzidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-6898","authenticated-orcid":false,"given":"Andishe","family":"Attarbaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3437-8338","authenticated-orcid":false,"given":"Liv","family":"Andres-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-4737","authenticated-orcid":false,"given":"Arndt","family":"Borkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Conde Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-3805","authenticated-orcid":false,"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie M.","family":"Hagleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-5246","authenticated-orcid":false,"given":"Christina","family":"Halsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Josephs-Spaulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9716-9264","authenticated-orcid":false,"given":"Sophia","family":"Polychronopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-3292","authenticated-orcid":false,"given":"Ulrik","family":"Stoltze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9871-7637","authenticated-orcid":false,"given":"Linea Natalie","family":"Toksvang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayo","family":"Wahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie Verena","family":"Junk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-4993","authenticated-orcid":false,"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"2804_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14844-6","volume":"11","author":"B Werner","year":"2020","unstructured":"Werner B, Case J, Williams MJ, Chkhaidze K, Temko D, Fern\u00e1ndez-Mateos J, et al. Measuring single cell divisions in human tissues from multi-region sequencing data. Nat Commun. 2020;11:1035.","journal-title":"Nat Commun"},{"key":"2804_CR2","doi-asserted-by":"crossref","unstructured":"Tulstrup M, Stoltze UK, Schmiegelow K, Yang. JJ Epidemiology and Etiology of Childhood ALL. In: Childhood Acute Lymphoblastic Leukemia 2017; pp 1\u201327.","DOI":"10.1007\/978-3-319-39708-5_1"},{"key":"2804_CR3","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1182\/blood-2014-12-580001","volume":"125","author":"T Moriyama","year":"2015","unstructured":"Moriyama T, Relling MV, Yang JJ. Inherited genetic variation in childhood acute lymphoblastic leukemia. Blood. 2015;125:3988\u201395.","journal-title":"Blood"},{"key":"2804_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.gde.2009.04.010","volume":"19","author":"NJ Schork","year":"2009","unstructured":"Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev. 2009;19:212.","journal-title":"Curr Opin Genet Dev"},{"key":"2804_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrg3118","volume":"13","author":"G Gibson","year":"2012","unstructured":"Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet. 2012;13:135.","journal-title":"Nat Rev Genet"},{"key":"2804_CR6","first-page":"1","volume":"2025","author":"U Stoltze","year":"2025","unstructured":"Stoltze U, Junk SV, Byrjalsen A, Cav\u00e9 H, Cazzaniga G, Elitzur S, et al. Overt and covert genetic causes of pediatric acute lymphoblastic leukemia. Leukemia. 2025;2025:1\u201315.","journal-title":"Leukemia"},{"key":"2804_CR7","doi-asserted-by":"publisher","unstructured":"Pagliaro L, Chen SJ, Herranz D, Mecucci C, Harrison CJ, Mullighan CG, et al. Acute lymphoblastic leukaemia. Nat Rev Dis Primers 2024; 10. https:\/\/doi.org\/10.1038\/S41572-024-00525-X.","DOI":"10.1038\/S41572-024-00525-X"},{"key":"2804_CR8","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","volume":"17","author":"K Schmiegelow","year":"2016","unstructured":"Schmiegelow K, Attarbaschi A, Barzilai S, Escherich G, Frandsen TL, Halsey C, et al. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol. 2016;17:e231\u20139.","journal-title":"Lancet Oncol"},{"key":"2804_CR9","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1016\/S2352-3026(21)00136-8","volume":"8","author":"L Andr\u00e9s-Jensen","year":"2021","unstructured":"Andr\u00e9s-Jensen L, Attarbaschi A, Bardi E, Barzilai-Birenboim S, Bhojwani D, Hagleitner MM, et al. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. Lancet Haematol. 2021;8:e513\u201323.","journal-title":"Lancet Haematol"},{"key":"2804_CR10","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1016\/S2352-3026(18)30070-X","volume":"5","author":"K Schmiegelow","year":"2018","unstructured":"Schmiegelow K, Frandsen TL. The cost of cure. Lancet Haematol. 2018;5:e504\u20135.","journal-title":"Lancet Haematol"},{"key":"2804_CR11","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/pon.5480","volume":"29","author":"L Andr\u00e9s-Jensen","year":"2020","unstructured":"Andr\u00e9s-Jensen L, Larsen HB, Johansen C, Frandsen TL, Schmiegelow K, Wahlberg A. Everyday life challenges among adolescent and young adult survivors of childhood acute lymphoblastic leukemia: An in-depth qualitative study. Psychooncology. 2020;29:1630\u20137.","journal-title":"Psychooncology"},{"key":"2804_CR12","doi-asserted-by":"publisher","unstructured":"Stoltze UK, Hansen T, Foss-Skiftesvik J, Byrjalsen A, Henriksen K, Laspiur A, et al. Causal germline variants in children with cancer. 2024. https:\/\/doi.org\/10.2139\/SSRN.4889581.","DOI":"10.2139\/SSRN.4889581"},{"key":"2804_CR13","first-page":"295","volume":"13","author":"D Maamari","year":"2020","unstructured":"Maamari D, El-Khoury H, Saifi O, Muwakkit SA, Zgheib NK. Implementation of pharmacogenetics to individualize treatment regimens for children with acute lymphoblastic leukemia. Pharmgenom Pers Med. 2020;13:295\u2013317.","journal-title":"Pharmgenom Pers Med"},{"key":"2804_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"2804_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-020-00001-2","volume":"1","author":"E Uffelmann","year":"2021","unstructured":"Uffelmann E, Huang QQ, Munung NS, de Vries J, Okada Y, Martin AR, et al. Genome-wide association studies. Nat Rev Methods Prim. 2021;1:1\u201321. 2021 1:1.","journal-title":"Nat Rev Methods Prim"},{"key":"2804_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00438-020-01647-z","volume":"295","author":"B Liang","year":"2020","unstructured":"Liang B, Ding H, Huang L, Luo H, Zhu X. GWAS in cancer: progress and challenges. Mol Genet Genomics. 2020;295:537\u201361.","journal-title":"Mol Genet Genomics"},{"key":"2804_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrg.2016.27","volume":"17","author":"N Chatterjee","year":"2016","unstructured":"Chatterjee N, Shi J, Garc\u00eda-Closas M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat Rev Genet. 2016;17:392\u2013406.","journal-title":"Nat Rev Genet"},{"key":"2804_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrg2760","volume":"11","author":"NA Rosenberg","year":"2010","unstructured":"Rosenberg NA, Huang L, Jewett EM, Szpiech ZA, Jankovic I, Boehnke M. Genome-wide association studies in diverse populations. Nat Rev Genet. 2010;11:356\u201366.","journal-title":"Nat Rev Genet"},{"key":"2804_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fgene.2018.00352","volume":"9","author":"T Wang","year":"2018","unstructured":"Wang T, Hosgood HD, Lan Q, Xue X. The relationship between population attributable fraction and heritability in genetic studies. Front Genet. 2018;9:352.","journal-title":"Front Genet"},{"key":"2804_CR20","doi-asserted-by":"publisher","unstructured":"Moutsianas L, Agarwala V, Fuchsberger C, Flannick J, Rivas MA, Gaulton KJ, et al. The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease. PLoS Genet. 2015; 11. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1005165.","DOI":"10.1371\/JOURNAL.PGEN.1005165"},{"key":"2804_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41437-019-0205-3","volume":"123","author":"M Wang","year":"2019","unstructured":"Wang M, Xu S. Statistical power in genome-wide association studies and quantitative trait locus mapping. Heredity. 2019;123:287\u2013306.","journal-title":"Heredity"},{"key":"2804_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s10038-020-00845-2","volume":"66","author":"Y Momozawa","year":"2021","unstructured":"Momozawa Y, Mizukami K. Unique roles of rare variants in the genetics of complex diseases in humans. J Hum Genet. 2021;66:11\u201323.","journal-title":"J Hum Genet"},{"key":"2804_CR23","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/nprot.2007.366","volume":"2","author":"KT Zondervan","year":"2007","unstructured":"Zondervan KT, Cardon LR. Designing candidate gene and genome-wide case-control association studies. Nat Protoc. 2007;2:2492\u20132500.","journal-title":"Nat Protoc"},{"key":"2804_CR24","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/nprot.2010.116","volume":"5","author":"CA Anderson","year":"2010","unstructured":"Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc. 2010;5:1564\u201373.","journal-title":"Nat Protoc"},{"key":"2804_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrg2813","volume":"11","author":"AL Price","year":"2010","unstructured":"Price AL, Zaitlen NA, Reich D, Patterson N. New approaches to population stratification in genome-wide association studies. Nat Rev Genet. 2010;11:459\u201363.","journal-title":"Nat Rev Genet"},{"key":"2804_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ng1333","volume":"36","author":"ML Freedman","year":"2004","unstructured":"Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004;36:388\u201393.","journal-title":"Nat Genet"},{"key":"2804_CR27","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, et al. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet. 2022;54:1376\u201389.","journal-title":"Nat Genet"},{"key":"2804_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","volume":"583","author":"E Turro","year":"2020","unstructured":"Turro E, Astle WJ, Megy K, Gr\u00e4f S, Greene D, Shamardina O, et al. Whole-genome sequencing of patients with rare diseases in a national health system. Nature. 2020;583:96\u2013102.","journal-title":"Nature"},{"key":"2804_CR29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jnci\/djac101","volume":"114","author":"X Zhao","year":"2022","unstructured":"Zhao X, Qian M, Goodings C, Zhang Y, Yang W, Wang P, et al. Molecular mechanisms of ARID5B-mediated genetic susceptibility to acute lymphoblastic leukemia. J Natl Cancer Inst. 2022;114:1287\u201395.","journal-title":"J Natl Cancer Inst"},{"key":"2804_CR30","doi-asserted-by":"publisher","unstructured":"Luo L, Shen J, Zhang H, Chhibber A, Mehrotra DV, Tang ZZ. Multi-trait analysis of rare-variant association summary statistics using MTAR. Nat Commun 2020; 11. https:\/\/doi.org\/10.1038\/S41467-020-16591-0.","DOI":"10.1038\/S41467-020-16591-0"},{"key":"2804_CR31","doi-asserted-by":"publisher","unstructured":"Chen W, Wu Y, Zheng Z, Qi T, Visscher PM, Zhu Z et al. Improved analyses of GWAS summary statistics by reducing data heterogeneity and errors. Nat Commun 2021; 12. https:\/\/doi.org\/10.1038\/S41467-021-27438-7.","DOI":"10.1038\/S41467-021-27438-7"},{"key":"2804_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang Q, Dhindsa RS, Carss K, Harper AR, Nag A, Tachmazidou I, et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature. 2021;597:527\u201332.","journal-title":"Nature"},{"key":"2804_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/08880018.2023.2201302","volume":"41","author":"S Miyamoto","year":"2024","unstructured":"Miyamoto S, Urayama KY, Arakawa Y, Koh K, Yuza Y, Hasegawa D, et al. Rare TCF3 variants associated with pediatric B cell acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2024;41:81\u20137.","journal-title":"Pediatr Hematol Oncol"},{"key":"2804_CR34","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","volume":"632","author":"P P\u00f6l\u00f6nen","year":"2024","unstructured":"P\u00f6l\u00f6nen P, Di Giacomo D, Seffernick AE, Elsayed A, Kimura S, Benini F, et al. The genomic basis of childhood T-lineage acute lymphoblastic leukaemia. Nature. 2024;632:1082\u201391.","journal-title":"Nature"},{"key":"2804_CR35","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1158\/1078-0432.CCR-24-1165","volume":"30","author":"K Zelley","year":"2024","unstructured":"Zelley K, Schienda J, Gallinger B, Kohlmann WK, McGee RB, Scollon SR, et al. Update on genetic counselor practice and recommendations for pediatric cancer predisposition evaluation and surveillance. Clin Cancer Res. 2024;30:3983\u20139.","journal-title":"Clin Cancer Res"},{"key":"2804_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"2804_CR37","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/cpt.1304","volume":"105","author":"MV Relling","year":"2019","unstructured":"Relling MV, Schwab M, Whirl-Carrillo M, Suarez-Kurtz G, Pui CH, Stein CM, et al. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update. Clin Pharm Ther. 2019;105:1095\u2013105.","journal-title":"Clin Pharm Ther"},{"key":"2804_CR38","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.1200\/JCO.2008.20.4156","volume":"27","author":"LR Trevi\u00f1o","year":"2009","unstructured":"Trevi\u00f1o LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, et al. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol. 2009;27:5972\u20138.","journal-title":"J Clin Oncol"},{"key":"2804_CR39","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ng.430","volume":"41","author":"E Papaemmanuil","year":"2009","unstructured":"Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1006\u201310.","journal-title":"Nat Genet"},{"key":"2804_CR40","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1182\/blood-2013-03-491316","volume":"122","author":"G Migliorini","year":"2013","unstructured":"Migliorini G, Fiege B, Hosking FJ, Ma Y, Kumar R, Sherborne AL, et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood. 2013;122:3298\u2013307.","journal-title":"Blood"},{"key":"2804_CR41","doi-asserted-by":"publisher","unstructured":"Vijayakrishnan J, Henrion M, Moorman AV, Fiege B, Kumar R, Inacio Da Silva Filho M, et al. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A. Sci Rep 2015; 5. https:\/\/doi.org\/10.1038\/SREP15065.","DOI":"10.1038\/SREP15065"},{"key":"2804_CR42","doi-asserted-by":"publisher","unstructured":"Vijayakrishnan J, Studd J, Broderick P, Kinnersley B, Holroyd A, Law PJ et al. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. Nat Commun 2018; 9. https:\/\/doi.org\/10.1038\/S41467-018-03178-Z.","DOI":"10.1038\/S41467-018-03178-Z"},{"key":"2804_CR43","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","volume":"33","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Landier W, Yang W, Liu C, Hageman L, Cheng C, et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol. 2015;33:1235\u201342.","journal-title":"J Clin Oncol"},{"key":"2804_CR44","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/cpt.540","volume":"101","author":"R Tamm","year":"2017","unstructured":"Tamm R, M\u00e4gi R, Tremmel R, Winter S, Mihailov E, Smid A, et al. Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies. Clin Pharm Ther. 2017;101:684\u201395.","journal-title":"Clin Pharm Ther"},{"key":"2804_CR45","doi-asserted-by":"publisher","first-page":"E2248803","DOI":"10.1001\/jamanetworkopen.2022.48803","volume":"5","author":"W Yang","year":"2022","unstructured":"Yang W, Karol SE, Hoshitsuki K, Lee S, Larsen EC, Winick N, et al. Association of inherited genetic factors with drug-induced hepatic damage among children with acute lymphoblastic leukemia. JAMA Netw Open. 2022;5:E2248803.","journal-title":"JAMA Netw Open"},{"key":"2804_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/S13046-022-02585-X","volume":"42","author":"SV Junk","year":"2023","unstructured":"Junk SV, Schaeffeler E, Zimmermann M, M\u00f6ricke A, Beier R, Sch\u00fctte P, et al. Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group. J Exp Clin Cancer Res. 2023;42:21. https:\/\/doi.org\/10.1186\/S13046-022-02585-X.","journal-title":"J Exp Clin Cancer Res"},{"key":"2804_CR47","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1182\/blood-2015-05-643601","volume":"126","author":"SE Karol","year":"2015","unstructured":"Karol SE, Yang W, Van Driest SL, Chang TY, Kaste S, Bowton E, et al. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2015;126:1770\u20136.","journal-title":"Blood"},{"key":"2804_CR48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3324\/haematol.2020.268565","volume":"107","author":"MK Mateos","year":"2022","unstructured":"Mateos MK, Marshall GM, Barbaro PM, Quinn MCJ, George C, Mayoh C, et al. Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia. Haematologica. 2022;107:635\u201343.","journal-title":"Haematologica"},{"key":"2804_CR49","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1182\/blood.2020008471","volume":"137","author":"W Yang","year":"2021","unstructured":"Yang W, Devidas M, Liu Y, Smith C, Dai Y, Winick N, et al. Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations. Blood. 2021;137:1550\u20132.","journal-title":"Blood"},{"key":"2804_CR50","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3349\/ymj.2014.55.1.232","volume":"55","author":"JY Kim","year":"2014","unstructured":"Kim JY, Cheong HS, Park BL, Kim LH, Namgoong S, Kim JO, et al. Comprehensive variant screening of the UGT gene family. Yonsei Med J. 2014;55:232\u20139.","journal-title":"Yonsei Med J"},{"key":"2804_CR51","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","volume":"95","author":"E Beutler","year":"1998","unstructured":"Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad Sci USA. 1998;95:8170\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2804_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0168-8278(02)00359-8","volume":"38","author":"PJ Bosma","year":"2003","unstructured":"Bosma PJ. Inherited disorders of bilirubin metabolism. J Hepatol. 2003;38:107\u201317.","journal-title":"J Hepatol"},{"key":"2804_CR53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle H, Haunstrup Clemmensen I, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome. Lancet. 2000;355:165\u20139.","journal-title":"Lancet"},{"key":"2804_CR54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jcp.54.7.512","volume":"54","author":"J Boultwood","year":"2001","unstructured":"Boultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol. 2001;54:512\u20136.","journal-title":"J Clin Pathol"},{"key":"2804_CR55","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1182\/blood-2023-191249","volume":"142","author":"R Sharma","year":"2023","unstructured":"Sharma R, Magnarelli A, Liu Q, Wang F, Yasui Y, Ehrhardt MJ, et al. Incidence and prognosis of primary malignancies in Ataxia-Telangiectasia Patients: A Report from the Ataxia-Telangiectasia Clinical Center (ATCC). Blood. 2023;142:6091.","journal-title":"Blood"},{"key":"2804_CR56","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1158\/1078-0432.CCR-23-3994","volume":"30","author":"A Das","year":"2024","unstructured":"Das A, MacFarland SP, Meade J, Hansford JR, Schneider KW, Kuiper RP, et al. Clinical updates and surveillance recommendations for DNA replication repair deficiency syndromes in children and young adults. Clin Cancer Res. 2024;30:3378\u201387.","journal-title":"Clin Cancer Res"},{"key":"2804_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2020.10.013","volume":"84","author":"TH Tran","year":"2022","unstructured":"Tran TH, Hunger SP. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Semin Cancer Biol. 2022;84:144\u201352.","journal-title":"Semin Cancer Biol"},{"key":"2804_CR58","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/2159-8290.CD-23-1091","volume":"14","author":"C Cobaleda","year":"2024","unstructured":"Cobaleda C, Godley LA, Nichols KE, Wlodarski MW, Sanchez-Garcia I. Insights into the molecular mechanisms of genetic predisposition to hematopoietic malignancies: the importance of gene-environment interactions. Cancer Discov. 2024;14:396\u2013405.","journal-title":"Cancer Discov"},{"key":"2804_CR59","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1182\/blood.2024024283","volume":"144","author":"S Elitzur","year":"2024","unstructured":"Elitzur S, Shiloh R, Loeffen JLC, Pastorczak A, Takagi M, Bomken S, et al. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies. Blood. 2024;144:1193\u2013205.","journal-title":"Blood"},{"key":"2804_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/17474086.2020.1685866","volume":"13","author":"M Bloom","year":"2020","unstructured":"Bloom M, Maciaszek JL, Clark ME, Pui CH, Nichols KE. Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia. Expert Rev Hematol. 2020;13:55\u201370.","journal-title":"Expert Rev Hematol"},{"key":"2804_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17374-3","volume":"11","author":"AC Fahed","year":"2020","unstructured":"Fahed AC, Wang M, Homburger JR, Patel AP, Bick AG, Neben CL, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun. 2020;11:1\u20139.","journal-title":"Nat Commun"},{"key":"2804_CR62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, et al. Variant interpretation using population databases: Lessons from gnomAD. Hum Mutat. 2022;43:1012\u201330.","journal-title":"Hum Mutat"},{"key":"2804_CR63","doi-asserted-by":"publisher","unstructured":"Porubsky D, Dashnow H, Sasani TA, Logsdon GA, Hallast P, Noyes MD, et al. Human de novo mutation rates from a four-generation pedigree reference. https:\/\/doi.org\/10.1038\/s41586-025-08922-2.","DOI":"10.1038\/s41586-025-08922-2"},{"key":"2804_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-024-45975-9","volume":"15","author":"UK Stoltze","year":"2024","unstructured":"Stoltze UK, Foss-Skiftesvik J, Hansen TvanO, Rasmussen S, Karczewski KJ, Wadt KAW, et al. The evolutionary impact of childhood cancer on the human gene pool. Nat Commun. 2024;15:1881. https:\/\/doi.org\/10.1038\/S41467-024-45975-9.","journal-title":"Nat Commun"},{"key":"2804_CR65","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3177","volume":"47","author":"MY Zhang","year":"2015","unstructured":"Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015;47:180\u20135.","journal-title":"Nat Genet"},{"key":"2804_CR66","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S1470-2045(15)00369-1","volume":"16","author":"T Moriyama","year":"2015","unstructured":"Moriyama T, Metzger ML, Wu G, Nishii R, Qian M, Devidas M, et al. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study. Lancet Oncol. 2015;16:1659\u201366.","journal-title":"Lancet Oncol"},{"key":"2804_CR67","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1182\/blood.2023023326","volume":"143","author":"J Ryu","year":"2024","unstructured":"Ryu J, R\u00e4m\u00f6 JT, Jurgens SJ, Palotie A, Daly M, Riley-Gills B, et al. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank. Blood. 2024;143:2425\u201332.","journal-title":"Blood"},{"key":"2804_CR68","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/emph\/eoy033","volume":"2018","author":"SN Austad","year":"2018","unstructured":"Austad SN, Hoffman JM. Is antagonistic pleiotropy ubiquitous in aging biology? Evol Med Public Health. 2018;2018:287\u201394.","journal-title":"Evol Med Public Health"},{"key":"2804_CR69","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra0905980","volume":"363","author":"TA Manolio","year":"2010","unstructured":"Manolio TA. Genomewide Association Studies and Assessment of the Risk of Disease. N Engl J Med. 2010;363:166\u201376.","journal-title":"N Engl J Med"},{"key":"2804_CR70","doi-asserted-by":"crossref","unstructured":"Stoltze UK, Brozou T, Schmiegelow K, Borkhardt A. Genetic Predisposition for Acute Lymphoblastic Leukemia. Pediatric Oncology 2024; Part F4057: 3\u201318.","DOI":"10.1007\/978-3-031-71180-0_1"},{"key":"2804_CR71","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/leu.2012.89","volume":"26","author":"V Enciso-Mora","year":"2012","unstructured":"Enciso-Mora V, Hosking FJ, Sheridan E, Kinsey SE, Lightfoot T, Roman E, et al. Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia. 2012;26:2212\u20135.","journal-title":"Leukemia"},{"key":"2804_CR72","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105:2524\u201339.","journal-title":"Haematologica"},{"key":"2804_CR73","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1158\/0008-5472.CAN-15-1105","volume":"75","author":"KM Walsh","year":"2015","unstructured":"Walsh KM, De Smith AJ, Hansen HM, Smirnov IV, Gonseth S, Endicott AA, et al. A Heritable Missense polymorphism in CDKN2A confers strong risk of childhood acute lymphoblastic leukemia and is preferentially selected during clonal evolution. Cancer Res. 2015;75:4884\u201394.","journal-title":"Cancer Res"},{"key":"2804_CR74","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.tips.2022.07.002","volume":"43","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Tremmel R, Schaeffeler E, Schwab M, Lauschke VM. Challenges and opportunities associated with rare-variant pharmacogenomics. Trends Pharm Sci. 2022;43:852\u201365.","journal-title":"Trends Pharm Sci"},{"key":"2804_CR75","doi-asserted-by":"publisher","unstructured":"Cobaleda C, Vicente-Due\u00f1as C, Nichols KE, Sanchez-Garcia I. Childhood B cell leukemia: Intercepting the paths to progression. Bioessays 2024; 46. https:\/\/doi.org\/10.1002\/BIES.202400033.","DOI":"10.1002\/BIES.202400033"},{"key":"2804_CR76","doi-asserted-by":"publisher","unstructured":"Byrjalsen A, Hansen TVO, Stoltze UK, Mehrjouy MM, Barnkob NM, Hjalgrim LL, et al. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes. PLoS Genet 2020; 16. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1009231.","DOI":"10.1371\/JOURNAL.PGEN.1009231"},{"key":"2804_CR77","first-page":"1247","volume":"109","author":"M Hangai","year":"2024","unstructured":"Hangai M, Kawaguchi T, Takagi M, Matsuo K, Jeon S, Chiang CWK, et al. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients. Haematologica. 2024;109:1247\u201352.","journal-title":"Haematologica"},{"key":"2804_CR78","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/FPC.0000000000000451","volume":"32","author":"C Li","year":"2022","unstructured":"Li C, Zhao X, He Y, Li Z, Qian J, Zhang L, et al. The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia. Pharmacogenet Genomics. 2022;32:43\u201350.","journal-title":"Pharmacogenet Genomics"},{"key":"2804_CR79","doi-asserted-by":"publisher","unstructured":"Zerella JR, Homan CC, Arts P, Lin X, Spinelli SJ, Venugopal P, et al. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition. Blood 2024; 144. https:\/\/doi.org\/10.1182\/BLOOD.2024024607.","DOI":"10.1182\/BLOOD.2024024607"},{"key":"2804_CR80","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1158\/1055-9965.EPI-20-0113","volume":"29","author":"EC Semmes","year":"2020","unstructured":"Semmes EC, Vijayakrishnan J, Zhang C, Hurst JH, Houlston RS, Walsh KM. Leveraging genome and phenome-wide association studies to investigate genetic risk of acute lymphoblastic leukemia. Cancer Epidemiol Biomark Prev. 2020;29:1606\u201314.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2804_CR81","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/ng.2803","volume":"45","author":"V Perez-Andreu","year":"2013","unstructured":"Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet. 2013;45:1494\u20138.","journal-title":"Nat Genet"},{"key":"2804_CR82","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ng.432","volume":"41","author":"LR Trev\u0129o","year":"2009","unstructured":"Trev\u0129o LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1001\u20135.","journal-title":"Nat Genet"},{"key":"2804_CR83","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jnci\/djt042","volume":"105","author":"H Xu","year":"2013","unstructured":"Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst. 2013;105:733\u201342.","journal-title":"J Natl Cancer Inst"},{"key":"2804_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/NCOMMS8553","volume":"6","author":"H Xu","year":"2015","unstructured":"Xu H, Zhang H, Yang W, Yadav R, Morrison AC, Qian M, et al. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nat Commun. 2015;6:7553. https:\/\/doi.org\/10.1038\/NCOMMS8553.","journal-title":"Nat Commun"},{"key":"2804_CR85","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/leu.2011.302","volume":"26","author":"E Ellinghaus","year":"2012","unstructured":"Ellinghaus E, Stanulla M, Richter G, Ellinghaus D, Te Kronnie G, Cario G, et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia. 2012;26:902\u20139.","journal-title":"Leukemia"},{"key":"2804_CR86","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/blood-2009-09-241513","volume":"115","author":"RB Prasad","year":"2010","unstructured":"Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood. 2010;115:1765\u20137.","journal-title":"Blood"},{"key":"2804_CR87","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ng.585","volume":"42","author":"AL Sherborne","year":"2010","unstructured":"Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42:492\u20134.","journal-title":"Nat Genet"},{"key":"2804_CR88","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/jnci\/djaa133","volume":"113","author":"SHR Lee","year":"2021","unstructured":"Lee SHR, Qian M, Yang W, Diedrich JD, Raetz E, Yang W, et al. Genome-wide association study of susceptibility Loci for TCF3-PBX1 acute lymphoblastic leukemia in children. J Natl Cancer Inst. 2021;113:933\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"2804_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-019-13069-6","volume":"10","author":"J Vijayakrishnan","year":"2019","unstructured":"Vijayakrishnan J, Qian M, Studd JB, Yang W, Kinnersley B, Law PJ, et al. Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk. Nat Commun. 2019;10:5348. https:\/\/doi.org\/10.1038\/S41467-019-13069-6.","journal-title":"Nat Commun"},{"key":"2804_CR90","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.leu.2404884","volume":"22","author":"M Kamper-J\u00f8rgensen","year":"2007","unstructured":"Kamper-J\u00f8rgensen M, Woodward A, Wohlfahrt J, Benn CS, Simonsen J, Hjalgrim H, et al. Childcare in the first 2 years of life reduces the risk of childhood acute lymphoblastic leukemia. Leukemia. 2007;22:189\u201393.","journal-title":"Leukemia"},{"key":"2804_CR91","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/ije\/dyp378","volume":"39","author":"KY Urayama","year":"2010","unstructured":"Urayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X. A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol. 2010;39:718\u201332.","journal-title":"Int J Epidemiol"},{"key":"2804_CR92","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/CANCERS14020382","volume":"14","author":"FM Onyije","year":"2022","unstructured":"Onyije FM, Olsson A, Baaken D, Erdmann F, Stanulla M, Wollschl\u00e4ger D, et al. Environmental risk factors for childhood acute lymphoblastic leukemia: an umbrella review. Cancers. 2022;14:382 https:\/\/doi.org\/10.3390\/CANCERS14020382.","journal-title":"Cancers"},{"key":"2804_CR93","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1158\/1055-9965.EPI-23-0258","volume":"32","author":"C Zhong","year":"2023","unstructured":"Zhong C, Li S, Arroyo K, Morimoto LM, De Smith AJ, Metayer C, et al. Gene-environment analyses reveal novel genetic candidates with prenatal tobacco exposure in relation to risk for childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomark Prev. 2023;32:1707\u201315.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2804_CR94","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1182\/blood-2008-07-165928","volume":"113","author":"R De Jonge","year":"2009","unstructured":"De Jonge R, Tissing WJE, Hooijberg JH, Jansen G, Kaspers GJL, Lindemans J, et al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood. 2009;113:2284\u20139.","journal-title":"Blood"},{"key":"2804_CR95","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1182\/blood-2003-06-1794","volume":"103","author":"M Krajinovic","year":"2004","unstructured":"Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard \u00c9, Th\u00e9or\u00eat Y, Moqhrabi A, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood. 2004;103:252\u20137.","journal-title":"Blood"},{"key":"2804_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.639479","volume":"9","author":"EL Marcotte","year":"2021","unstructured":"Marcotte EL, Spector LG, Mendes-de-Almeida DP, Nelson HH. The prenatal origin of childhood leukemia: potential applications for epidemiology and newborn screening. Front Pediatr. 2021;9:639479.","journal-title":"Front Pediatr"},{"key":"2804_CR97","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1182\/blood-2017-09-808402","volume":"131","author":"D Sch\u00e4fer","year":"2018","unstructured":"Sch\u00e4fer D, Olsen M, L\u00e4hnemann D, Stanulla M, Slany R, Schmiegelow K, et al. Five percent of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening. Blood. 2018;131:821\u20136.","journal-title":"Blood"},{"key":"2804_CR98","doi-asserted-by":"publisher","first-page":"e0121348","DOI":"10.1371\/journal.pone.0121348","volume":"10","author":"J Rudant","year":"2015","unstructured":"Rudant J, Orsi L, Bonaventure A, Goujon-Bellec S, Baruchel A, Petit A, et al. ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: The ESCALE study. PLoS One. 2015;10:e0121348.","journal-title":"PLoS One"},{"key":"2804_CR99","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3324\/haematol.2022.281157","volume":"108","author":"C Goodings","year":"2023","unstructured":"Goodings C, Zhao X, McKinney-Freeman S, Zhang H, Yang JJ. ARID5B influences B-cell development and function in mouse. Haematologica. 2023;108:502\u201312.","journal-title":"Haematologica"},{"key":"2804_CR100","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-0609.2010.01522.x","volume":"86","author":"G Vaitkevi\u010dien\u0117","year":"2011","unstructured":"Vaitkevi\u010dien\u0117 G, Forestier E, Hellebostad M, Heyman M, Jonsson OG, L\u00e4hteenm\u00e4ki PM, et al. High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. Eur J Haematol. 2011;86:38\u201346.","journal-title":"Eur J Haematol"},{"key":"2804_CR101","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/ejh.12097","volume":"90","author":"N Toft","year":"2013","unstructured":"Toft N, Birgens H, Abrahamsson J, Bernell P, Gri\u0161kevi\u010dius L, Hallb\u00f6\u00f6k H, et al. Risk group assignment differs for children and adults 1\u201345\u2009yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol. Eur J Haematol. 2013;90:404\u201312.","journal-title":"Eur J Haematol"},{"key":"2804_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29582","volume":"69","author":"M Helenius","year":"2022","unstructured":"Helenius M, Vaitkeviciene G, Abrahamsson J, Jonsson \u00d3G, Lund B, Harila-Saari A, et al. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype\u2013genotype study. Pediatr Blood Cancer. 2022;69:e29582.","journal-title":"Pediatr Blood Cancer"},{"key":"2804_CR103","doi-asserted-by":"publisher","unstructured":"Thastrup M, Marquart HV, Schmiegelow K Flow Cytometric Detection of Malignant Blasts in Cerebrospinal Fluid: A Biomarker of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia. Biomolecules 2022; 12. https:\/\/doi.org\/10.3390\/BIOM12060813.","DOI":"10.3390\/BIOM12060813"},{"key":"2804_CR104","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41375-019-0570-1","volume":"34","author":"M Thastrup","year":"2020","unstructured":"Thastrup M, Marquart HV, Levinsen M, Grell K, Abrahamsson J, Albertsen BK, et al. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study. Leukemia. 2020;34:336\u201346.","journal-title":"Leukemia"},{"key":"2804_CR105","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1038\/s41375-022-01714-x","volume":"36","author":"M Thastrup","year":"2022","unstructured":"Thastrup M, Duguid A, Mirian C, Schmiegelow K, Halsey C. Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions. Leukemia. 2022;36:2751\u201368.","journal-title":"Leukemia"},{"key":"2804_CR106","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41375-022-01591-4","volume":"36","author":"LN Toksvang","year":"2022","unstructured":"Toksvang LN, Lee SHR, Yang JJ, Schmiegelow K. Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations. Leukemia. 2022;36:1749\u201358.","journal-title":"Leukemia"},{"key":"2804_CR107","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1038\/s41375-018-0245-3","volume":"32","author":"M Tulstrup","year":"2018","unstructured":"Tulstrup M, Grosjean M, Nielsen SN, Grell K, Wolthers BO, Wegener PS, et al. NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia. Leukemia. 2018;32:2527\u201335.","journal-title":"Leukemia"},{"key":"2804_CR108","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/cpt.2095","volume":"109","author":"C Jiang","year":"2021","unstructured":"Jiang C, Yang W, Moriyama T, Liu C, Smith C, Yang W, et al. Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia. Clin Pharm Ther. 2021;109:1538\u201345.","journal-title":"Clin Pharm Ther"},{"key":"2804_CR109","doi-asserted-by":"publisher","unstructured":"Taylor ZL, Vang J, Lopez-Lopez E, Oosterom N, Mikkelsen T, Ramsey LB. Systematic review of pharmacogenetic factors that influence high-dose Methotrexate pharmacokinetics in pediatric malignancies. Cancers 2021; 13. https:\/\/doi.org\/10.3390\/CANCERS13112837.","DOI":"10.3390\/CANCERS13112837"},{"key":"2804_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gr.129668.111","volume":"22","author":"LB Ramsey","year":"2012","unstructured":"Ramsey LB, Bruun GH, Yang W, Trevi\u00f1o LR, Vattathil S, Scheet P, et al. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res. 2012;22:1\u20138.","journal-title":"Genome Res"},{"key":"2804_CR111","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1182\/blood-2012-08-452839","volume":"121","author":"LB Ramsey","year":"2013","unstructured":"Ramsey LB, Panetta JC, Smith C, Yang W, Fan Y, Winick NJ, et al. Genome-wide study of methotrexate clearance replicates SLCO1B1. Blood. 2013;121:898\u2013904.","journal-title":"Blood"},{"key":"2804_CR112","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1182\/blood.2020005064","volume":"136","author":"M Tulstrup","year":"2020","unstructured":"Tulstrup M, Moriyama T, Jiang C, Grosjean M, Nersting J, Abrahamsson J, et al. Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia. Blood. 2020;136:1161\u20138.","journal-title":"Blood"},{"key":"2804_CR113","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/10428190902893819","volume":"50","author":"M Kantar","year":"2009","unstructured":"Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, Zafer N, et al. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Leuk Lymphoma. 2009;50:912\u20137.","journal-title":"Leuk Lymphoma"},{"key":"2804_CR114","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/sj.leu.2402428","volume":"16","author":"JW Taub","year":"2002","unstructured":"Taub JW, Matherly LH, Ravindranath Y, Kaspers GJL, Rots MG, van, et al. Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia. Leukemia. 2002;16:764\u20135.","journal-title":"Leukemia"},{"key":"2804_CR115","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1515\/biol-2021-0121","volume":"16","author":"Y Shen","year":"2021","unstructured":"Shen Y, Wang Z, Zhou F, Jin R. The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia. Open Life Sci. 2021;16:1203\u201312.","journal-title":"Open Life Sci"},{"key":"2804_CR116","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1600-0609.2008.01128.x","volume":"81","author":"PB Van Kooten Niekerk","year":"2008","unstructured":"Van Kooten Niekerk PB, Schmiegelow K, Schroeder H. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate. Eur J Haematol. 2008;81:391\u20138.","journal-title":"Eur J Haematol"},{"key":"2804_CR117","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s13277-012-0395-2","volume":"33","author":"L Yang","year":"2012","unstructured":"Yang L, Hu X, Xu L. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis. Tumour Biol. 2012;33:1445\u201354.","journal-title":"Tumour Biol"},{"key":"2804_CR118","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/tpj.2012.44","volume":"13","author":"E Lopez-Lopez","year":"2013","unstructured":"Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, Garcia-Orad A. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia. Pharmacogenom J. 2013;13:498\u2013506.","journal-title":"Pharmacogenom J"},{"key":"2804_CR119","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/10245332.2018.1500750","volume":"24","author":"P Yao","year":"2019","unstructured":"Yao P, He X, Zhang R, Tong R, Xiao H. The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis. Hematology. 2019;24:10\u201319.","journal-title":"Hematology"},{"key":"2804_CR120","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/MPH.0b013e3181868570","volume":"30","author":"ML Davidsen","year":"2008","unstructured":"Davidsen ML, Dalhoff K, Schmiegelow K. Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008;30:831\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2804_CR121","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/clpt.2010.94","volume":"88","author":"SH Chen","year":"2010","unstructured":"Chen SH, Pei D, Yang W, Cheng C, Jeha S, Cox NJ, et al. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clin Pharm Ther. 2010;88:191\u20136.","journal-title":"Clin Pharm Ther"},{"key":"2804_CR122","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.3109\/10428194.2015.1020802","volume":"56","author":"V Raji\u0107","year":"2015","unstructured":"Raji\u0107 V, Debeljak M, Gori\u010dar K, Jazbec J. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2015;56:3103\u20138.","journal-title":"Leuk Lymphoma"},{"key":"2804_CR123","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/sj.leu.2403521","volume":"18","author":"B Meissner","year":"2004","unstructured":"Meissner B, Stanulla M, Ludwig WD, Harbott J, M\u00f6ricke A, Welte K, et al. The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia [8]. Leukemia. 2004;18:1920\u20133.","journal-title":"Leukemia"},{"key":"2804_CR124","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2478\/raon-2018-0034","volume":"52","author":"V Gasic","year":"2018","unstructured":"Gasic V, Zukic B, Stankovic B, Janic D, Dokmanovic L, Lazic J, et al. Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia. Radio Oncol. 2018;52:296.","journal-title":"Radio Oncol"},{"key":"2804_CR125","doi-asserted-by":"publisher","first-page":"634956","DOI":"10.3389\/fphar.2021.634956","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu H, Li Z, Qiu F, Li C, Lin X, He Y, et al. Association between NR3C1 mutations and Glucocorticoid resistance in children with acute lymphoblastic leukemia. Front Pharm. 2021;12:634956.","journal-title":"Front Pharm"},{"key":"2804_CR126","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1200\/JCO.22.02705","volume":"41","author":"R Pieters","year":"2023","unstructured":"Pieters R, De Groot-Kruseman H, Fiocco M, Verwer F, Van Overveld M, Sonneveld E, et al. Improved outcome for ALL by prolonging therapy for IKZF1 deletion and decreasing therapy for other risk groups. J Clin Oncol. 2023;41:4130\u201342.","journal-title":"J Clin Oncol"},{"key":"2804_CR127","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1200\/JCO.19.01086","volume":"38","author":"KW Maloney","year":"2020","unstructured":"Maloney KW, Devidas M, Wang C, Mattano LA, Friedmann AM, Buckley P, et al. Outcome in children with standard-risk B-cell acute lymphoblastic leukemia: results of Children\u2019s Oncology Group Trial AALL0331. J Clin Oncol. 2020;38:602\u201312.","journal-title":"J Clin Oncol"},{"key":"2804_CR128","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2411680","volume":"392","author":"S Gupta","year":"2024","unstructured":"Gupta S, Rau RE, Kairalla JA, Rabin KR, Wang C, Angiolillo AL, et al. Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children. N Engl J Med. 2024;392:875\u201391.","journal-title":"N Engl J Med"},{"key":"2804_CR129","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJM Van Dongen","year":"1998","unstructured":"Van Dongen JJM, Seriu T, Panzer-Gr\u00fcmayer ER, Biondi A, Pongers-Willemse MJ, Corral L, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet. 1998;352:1731\u20138.","journal-title":"Lancet"},{"key":"2804_CR130","doi-asserted-by":"publisher","first-page":"e170580","DOI":"10.1001\/jamaoncol.2017.0580","volume":"3","author":"DA Berry","year":"2017","unstructured":"Berry DA, Zhou S, Higley H, Mukundan L, Fu S, Reaman GH, et al. Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: A meta-analysis. JAMA Oncol. 2017;3:e170580.","journal-title":"JAMA Oncol"},{"key":"2804_CR131","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1182\/blood-2012-07-440107","volume":"120","author":"JJ Yang","year":"2012","unstructured":"Yang JJ, Cheng C, Devidas M, Cao X, Campana D, Yang W, et al. Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood. 2012;120:4197\u2013204.","journal-title":"Blood"},{"key":"2804_CR132","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/leu.2017.24","volume":"31","author":"SE Karol","year":"2017","unstructured":"Karol SE, Larsen E, Cheng C, Cao X, Yang W, Ramsey LB, et al. Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia. Leukemia. 2017;31:1325\u201332.","journal-title":"Leukemia"},{"key":"2804_CR133","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/jnci\/djaa138","volume":"113","author":"H Zhang","year":"2021","unstructured":"Zhang H, Liu APY, Devidas M, Lee SHR, Cao X, Pei D, et al. Association of GATA3 polymorphisms with minimal residual disease and relapse risk in childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 2021;113:408\u201317.","journal-title":"J Natl Cancer Inst"},{"key":"2804_CR134","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/bio.2015.0032","volume":"13","author":"LJ Carithers","year":"2015","unstructured":"Carithers LJ, Ardlie K, Barcus M, Branton PA, Britton A, Buia SA, et al. A novel approach to high-quality postmortem tissue procurement: The GTEx Project. Biopreserv Biobank. 2015;13:311\u20137.","journal-title":"Biopreserv Biobank"},{"key":"2804_CR135","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cpt.2350","volume":"110","author":"M Whirl-Carrillo","year":"2021","unstructured":"Whirl-Carrillo M, Huddart R, Gong L, Sangkuhl K, Thorn CF, Whaley R, et al. An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clin Pharm Ther. 2021;110:563\u201372.","journal-title":"Clin Pharm Ther"},{"key":"2804_CR136","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/leu.2014.205","volume":"29","author":"A Weso\u0142owska-Andersen","year":"2015","unstructured":"Weso\u0142owska-Andersen A, Borst L, Dalgaard MD, Yadav R, Rasmussen KK, Wehner PS, et al. Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients. Leukemia. 2015;29:297\u2013303.","journal-title":"Leukemia"},{"key":"2804_CR137","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1097\/MPH.0000000000002292","volume":"44","author":"RL Nielsen","year":"2022","unstructured":"Nielsen RL, Wolthers BO, Helenius M, Albertsen BK, Clemmensen L, Nielsen K, et al. Can machine learning models predict Asparaginase-associated Pancreatitis in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2022;44:E628\u201336.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2804_CR138","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.thromres.2019.11.002","volume":"184","author":"KB Jarvis","year":"2019","unstructured":"Jarvis KB, LeBlanc M, Tulstrup M, Nielsen RL, Albertsen BK, Gupta R, et al. Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study. Thromb Res. 2019;184:92\u201398.","journal-title":"Thromb Res"},{"key":"2804_CR139","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40487-020-00111-7","volume":"8","author":"T Tiruneh","year":"2020","unstructured":"Tiruneh T, Enawgaw B, Shiferaw E. Genetic pathway in the pathogenesis of therapy-related myeloid neoplasms: a literature review. Oncol Ther. 2020;8:45.","journal-title":"Oncol Ther"},{"key":"2804_CR140","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.3390\/IJMS23179824","volume":"23","author":"NA Lomov","year":"2022","unstructured":"Lomov NA, Viushkov VS, Ulianov SV, Gavrilov AA, Alexeyevsky DA, Artemov AV, et al. Recurrent translocations in topoisomerase inhibitor-related leukemia are determined by the features of DNA breaks rather than by the proximity of the translocating genes. Int J Mol Sci. 2022;23:9824 https:\/\/doi.org\/10.3390\/IJMS23179824.","journal-title":"Int J Mol Sci"},{"key":"2804_CR141","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2009.27.0090","volume":"28","author":"AJ Taylor","year":"2010","unstructured":"Taylor AJ, Little MP, Winter DL, Sugden E, Ellison DW, Stiller CA, et al. Population-based risks of CNS tumors in survivors of childhood cancer: The British Childhood Cancer Survivor Study. J Clin Oncol. 2010;28:5287.","journal-title":"J Clin Oncol"},{"key":"2804_CR142","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/modpathol.2009.131","volume":"22","author":"RP Hasserjian","year":"2009","unstructured":"Hasserjian RP, Chen S, Perkins SL, De Leval L, Kinney MC, Barry TS, et al. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol. 2009;22:1532\u201340.","journal-title":"Mod Pathol"},{"key":"2804_CR143","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1200\/JCO.2017.75.5215","volume":"36","author":"M Qian","year":"2018","unstructured":"Qian M, Cao X, Devidas M, Yang W, Cheng C, Dai Y, et al. TP53 germline variations influence the predisposition and prognosis of B-cell acute lymphoblastic leukemia in children. J Clin Oncol. 2018;36:591\u20139.","journal-title":"J Clin Oncol"},{"key":"2804_CR144","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41375-021-01163-y","volume":"35","author":"G Winter","year":"2021","unstructured":"Winter G, Kirschner-Schwabe R, Groeneveld-Krentz S, Escherich G, M\u00f6ricke A, von Stackelberg A, et al. Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li\u2013Fraumeni syndrome. Leukemia. 2021;35:1475\u20139.","journal-title":"Leukemia"},{"key":"2804_CR145","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1200\/JCO.2012.47.0500","volume":"31","author":"K Schmiegelow","year":"2013","unstructured":"Schmiegelow K, Levinsen F, Attarbaschi A, Baruchel A, Devidas M, Escherich G, et al. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. J Clin Oncol. 2013;31:2469\u201376.","journal-title":"J Clin Oncol"},{"key":"2804_CR146","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1182\/blood-2008-11-187880","volume":"113","author":"K Schmiegelow","year":"2009","unstructured":"Schmiegelow K, Al-Modhwahi I, Andersen MK, Behrendtz M, Forestier E, Hasle H, et al. Methotrexate\/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood. 2009;113:6077\u201384.","journal-title":"Blood"},{"key":"2804_CR147","doi-asserted-by":"publisher","unstructured":"Nielsen SN, Eriksson F, Rosthoej S, Andersen MK, Forestier E, Hasle H, et al. Children with low-risk acute lymphoblastic leukemia are at highest risk of second cancers. Pediatr Blood Cancer 2017; 64. https:\/\/doi.org\/10.1002\/PBC.26518.","DOI":"10.1002\/PBC.26518"},{"key":"2804_CR148","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41375-024-02173-2","volume":"38","author":"SV Junk","year":"2024","unstructured":"Junk SV, F\u00f6rster A, Schmidt G, Zimmermann M, Fedders B, Haermeyer B, et al. Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia-a case-control study. Leukemia. 2024;38:887\u201392.","journal-title":"Leukemia"},{"key":"2804_CR149","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1200\/JCO.1992.10.1.156","volume":"10","author":"SP Hunger","year":"1992","unstructured":"Hunger SP, Sklar J, Link MP. Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol. 1992;10:156\u201363.","journal-title":"J Clin Oncol"},{"key":"2804_CR150","doi-asserted-by":"publisher","unstructured":"Byrjalsen A, Stoltze U, Wadt K, Hjalgrim LL, Gerdes AM, Schmiegelow K et al. Pediatric cancer families\u2019 participation in whole-genome sequencing research in Denmark: Parent perspectives. Eur J Cancer Care 2018; 27. https:\/\/doi.org\/10.1111\/ECC.12877.","DOI":"10.1111\/ECC.12877"},{"key":"2804_CR151","doi-asserted-by":"publisher","first-page":"e2200323","DOI":"10.1200\/PO.22.00323","volume":"6","author":"BN Mandrell","year":"2022","unstructured":"Mandrell BN, Johnson LM, Caples M, Gattuso J, Maciaszek JL, Mostafavi R, et al. Parental preferences surrounding timing and content of consent conversations for clinical germline genetic testing following a child\u2019s new cancer diagnosis. JCO Precis Oncol. 2022;6:e2200323 https:\/\/doi.org\/10.1200\/PO.22.00323.","journal-title":"JCO Precis Oncol"},{"key":"2804_CR152","doi-asserted-by":"publisher","unstructured":"Byrjalsen A, Stoltze UK, Castor A, Wahlberg A. Germline whole genome sequencing in pediatric oncology in Denmark-Practitioner perspectives. Mol Genet Genomic Med 2020; 8: e1276 https:\/\/doi.org\/10.1002\/MGG3.1276.","DOI":"10.1002\/MGG3.1276"},{"key":"2804_CR153","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41431-024-01565-3","volume":"32","author":"SBB Bon","year":"2024","unstructured":"Bon SBB, Wouters RHP, Bakhuizen JJ, Jongmans MCJ, van den Heuvel-Eibrink MM, Grootenhuis MA. Experiences of pediatric cancer patients (age 12\u201318 years) with extensive germline sequencing for cancer predisposition: a qualitative study. Eur J Hum Genet. 2024;32:567\u201375.","journal-title":"Eur J Hum Genet"},{"key":"2804_CR154","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41593-023-01333-4","volume":"26","author":"MC de Hemptinne","year":"2023","unstructured":"de Hemptinne MC, Posthuma D. Addressing the ethical and societal challenges posed by genome-wide association studies of behavioral and brain-related traits. Nat Neurosci. 2023;26:932\u201341.","journal-title":"Nat Neurosci"},{"key":"2804_CR155","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13648470.2021.1893654","volume":"29","author":"LL Heinsen","year":"2022","unstructured":"Heinsen LL, Wahlberg A, Petersen HV. Surveillance life and the shaping of \u2018genetically at risk\u2019 chronicities in Denmark. Anthropol Med. 2022;29:29\u201344.","journal-title":"Anthropol Med"},{"key":"2804_CR156","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/mpo.10262","volume":"40","author":"Spinetta","year":"2003","unstructured":"Spinetta, Masera JJ, Jankovic G, Oppenheim M, Martins D, Arush AG, et al. Valid informed consent and participative decision-making in children with cancer and their parents: a report of the SIOP Working Committee on psychosocial issues in pediatric oncology. Med Pediatr Oncol. 2003;40:244\u20136.","journal-title":"Med Pediatr Oncol"},{"key":"2804_CR157","doi-asserted-by":"publisher","first-page":"e0258646","DOI":"10.1371\/JOURNAL.PONE.0258646","volume":"16","author":"DF Vears","year":"2021","unstructured":"Vears DF, Minion JT, Roberts SJ, Cummings J, Machirori M, Blell M, et al. Return of individual research results from genomic research: A systematic review of stakeholder perspectives. PLoS One. 2021;16:e0258646 https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0258646.","journal-title":"PLoS One"},{"key":"2804_CR158","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1002\/cncr.34917","volume":"129","author":"BC McGill","year":"2023","unstructured":"McGill BC, Wakefield CE, Tucker KM, Daly RA, Donoghoe MW, Vetsch J, et al. Parents\u2019 expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial. Cancer. 2023;129:3620\u201332.","journal-title":"Cancer"},{"key":"2804_CR159","doi-asserted-by":"publisher","unstructured":"Eichinger J, Elger BS, Kon\u00e9 I, Filges I, Shaw D, Zimmermann B et al. The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review. BMC Pediatr 2021; 21. https:\/\/doi.org\/10.1186\/S12887-021-02830-W.","DOI":"10.1186\/S12887-021-02830-W"},{"key":"2804_CR160","doi-asserted-by":"publisher","unstructured":"Laumann RD, Pedersen LL, Andr\u00e9s-Jensen L, M\u00f8lgaard C, Schmiegelow K, Frandsen TL et al. Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta-analysis. Pediatr Blood Cancer 2023; 70. https:\/\/doi.org\/10.1002\/PBC.30683,.","DOI":"10.1002\/PBC.30683"},{"key":"2804_CR161","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/ijlh.13173","volume":"42","author":"M Wiggins","year":"2020","unstructured":"Wiggins M, Stevenson W. Genetic predisposition in acute leukaemia. Int J Lab Hematol. 2020;42:75\u201381.","journal-title":"Int J Lab Hematol"},{"key":"2804_CR162","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/jamaoncol.2021.6826","volume":"8","author":"SHR Lee","year":"2022","unstructured":"Lee SHR, Antillon-Klussmann F, Pei D, Yang W, Roberts KG, Li Z, et al. Association of genetic ancestry with the molecular subtypes and prognosis of childhood acute lymphoblastic leukemia. JAMA Oncol. 2022;8:354\u201363.","journal-title":"JAMA Oncol"},{"key":"2804_CR163","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2019.08.051","volume":"179","author":"RE Peterson","year":"2019","unstructured":"Peterson RE, Kuchenbaecker K, Walters RK, Chen CY, Popejoy AB, Periyasamy S, et al. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell. 2019;179:589\u2013603.","journal-title":"Cell"},{"key":"2804_CR164","first-page":"A14","volume":"4","author":"B Levine","year":"2006","unstructured":"Levine B. What does the population attributable fraction mean?. Prev Chronic Dis. 2006;4:A14.","journal-title":"Prev Chronic Dis"},{"key":"2804_CR165","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2018.03.021","volume":"33","author":"ML Churchman","year":"2018","unstructured":"Churchman ML, Qian M, te Kronnie G, Zhang R, Yang W, Zhang H, et al. Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia. Cancer Cell. 2018;33:937\u201348.e8.","journal-title":"Cancer Cell"},{"key":"2804_CR166","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3324\/haematol.2018.199356","volume":"104","author":"BO Wolthers","year":"2019","unstructured":"Wolthers BO, Frandsen TL, Patel CJ, Abaji R, Attarbaschi A, Barzilai S, et al. Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report. Haematologica. 2019;104:556\u201363.","journal-title":"Haematologica"},{"key":"2804_CR167","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/jnci\/djz043","volume":"111","author":"M Qian","year":"2019","unstructured":"Qian M, Zhao X, Devidas M, Yang W, Gocho Y, Smith C, et al. Genome-wide association study of susceptibility loci for T-cell acute lymphoblastic leukemia in children. J Natl Cancer Inst. 2019;111:1350\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"2804_CR168","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00277-014-2186-x","volume":"94","author":"C Wang","year":"2015","unstructured":"Wang C, Chen J, Sun H, Sun L, Liu Y. CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls. Ann Hematol. 2015;94:181\u20135.","journal-title":"Ann Hematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02804-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02804-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02804-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:03:32Z","timestamp":1767985412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02804-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":168,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2804"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02804-2","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}